Physician-scientist and PhD candidate in Experimental Cardiology (UMCG) integrating clinical insight with translational research in biomarkers, high-throughput screening, and nanoparticle concepts. I design responsible, workable AI workflows for healthcare—prompt engineering, model/tool selection, and LLM-assisted prototyping—while keeping ethics, explainability, and MDR awareness at the center.
Bridge between clinical teams and developers; turn clinical needs into usable AI tools.
Co-developer of QGuard-Med (AI-driven patient prioritization with continuous biomarker tracking).
Committed to Moral AI Literacy: bias, accountability, model cards, and transparent deployment.
Relevant Experience
Nov 2018 – Feb 2025
Doctoral Researcher (PhD Candidate)
University Medical Center Groningen, Netherlands
OPLAH & Oxidative Stress: Biomarker workflows to explore cardio-renal mechanisms and heart failure.
Esquivel-Gaytan, A., et al. (2024). “404-error ‘Disease not found’: Unleashing the translational potential of omics approaches beyond traditional disease classification in heart failure research.”
European Journal of Heart Failure.
DOI: 10.1002/ejhf.3268
Integrates omics to challenge classical HF classification and reveal novel mechanisms.
Esquivel-Gaytan, A., et al. (2023). “A high-throughput screening strategy identifies adenosine 5′-monophosphate as a novel enhancer of the cardio-protective enzyme 5-oxoprolinase (OPLAH).”
European Heart Journal, 44(Suppl_2), ehad655.3130.
DOI: 10.1093/eurheartj/ehad655.3130
Discovers AMP as an OPLAH modulator with potential cardioprotection.
Vermeer, M.C.S.C., Esquivel-Gaytan, J.A., et al. (2022).
“A translation re-initiation variant in KLHL24 causes epidermolysis bullosa simplex and dilated cardiomyopathy via intermediate filament degradation.”
British Journal of Dermatology, 187(6), 1045–1048.
DOI: 10.1111/bjd.21832
Links KLHL24 variant to skin and cardiac phenotypes via filament degradation.
Languages
Spanish: Native
English: C1
Dutch: B1–B2 (actively studying)
French: A2
Catalan: A1
Certifications
Good Clinical Practice — NDAT CTN (2025)
Article 9 — Experiments on Animals Act License
ML-1 Laboratory Certificate
Elements of AI — University of Helsinki (completed)